Skip to main content
Premium Trial:

Request an Annual Quote

BioDiscovery, OGT Settle Microarray-Software Patent-Infringement Suit

NEW YORK, Oct. 23 (GenomeWeb News) - BioDiscovery and Oxford Gene Technology have settled the patent-infringement lawsuit filed by OGT in December 2002, the companies said today.


Terms of the settlement, which revolve around US Patent No. 6,054,270, allow BioDiscovery to continue selling its full line of microarray-image and data-analysis software, but does not give it a license to any OGT patents.


BioDiscovery's software "may not be used to make any oligonucleotide arrays coming within the scope of any OGT patent or analyze polynucleotides using oligonucleotide arrays coming within the scope of any OGT patent or according to any method claimed in any OGT Patent, unless the user has a license from OGT or uses arrays made by licensees of OGT," the companies said.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.